AU5953696A - Methods and compositions for inhibiting cytomegalovirus repl ication - Google Patents

Methods and compositions for inhibiting cytomegalovirus repl ication

Info

Publication number
AU5953696A
AU5953696A AU59536/96A AU5953696A AU5953696A AU 5953696 A AU5953696 A AU 5953696A AU 59536/96 A AU59536/96 A AU 59536/96A AU 5953696 A AU5953696 A AU 5953696A AU 5953696 A AU5953696 A AU 5953696A
Authority
AU
Australia
Prior art keywords
compositions
methods
inhibiting cytomegalovirus
repl ication
repl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59536/96A
Inventor
Charles E. Mckenna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Publication of AU5953696A publication Critical patent/AU5953696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU59536/96A 1995-06-06 1996-05-30 Methods and compositions for inhibiting cytomegalovirus repl ication Abandoned AU5953696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46829895A 1995-06-06 1995-06-06
US468298 1995-06-06
PCT/US1996/008029 WO1996039148A1 (en) 1995-06-06 1996-05-30 Methods and compositions for inhibiting cytomegalovirus replication

Publications (1)

Publication Number Publication Date
AU5953696A true AU5953696A (en) 1996-12-24

Family

ID=23859244

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59536/96A Abandoned AU5953696A (en) 1995-06-06 1996-05-30 Methods and compositions for inhibiting cytomegalovirus repl ication

Country Status (4)

Country Link
EP (1) EP0831842A4 (en)
AU (1) AU5953696A (en)
CA (1) CA2223874A1 (en)
WO (1) WO1996039148A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE320260T1 (en) * 1998-07-13 2006-04-15 Univ Southern California SULFUR CONTAINING PHOSPHONOFORMATE DERIVATIVES AND THEIR USE.
AU2006220459A1 (en) * 2005-03-07 2006-09-14 Adventrx Pharmaceuticals, Inc. The use of thiophosphonoformic acid and NRTIs to treat viral infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7607496L (en) * 1976-07-01 1978-01-02 Astra Laekemedel Ab METHOD FOR FIGHTING VIRUS INFECTIONS
US5183812A (en) * 1989-06-21 1993-02-02 Mckenna Charles E Preparation and use of thiophosphonates and thio-analogues of phosphonoformic acid
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use

Also Published As

Publication number Publication date
EP0831842A1 (en) 1998-04-01
CA2223874A1 (en) 1996-12-12
WO1996039148A1 (en) 1996-12-12
EP0831842A4 (en) 1998-08-19

Similar Documents

Publication Publication Date Title
AU5399898A (en) Method and compositions for weight control
AU5922096A (en) Methods and compositions for inhibiting 5alpha-reductase act ivity
AU6898996A (en) Compositions and methods for growth promotion
AU5636898A (en) Methods and compositions for controlling plant development
AU6332996A (en) Androgenic directed compositions
AU1301697A (en) Tyrosin-derivate as alpha-v-integrin inhibitors
AU6856496A (en) Compositions and methods for inhibiting corrosion
AU4699996A (en) Epoxy-cyanate ester compositions
AU5979496A (en) Composition and methods for losing weight
AU5855796A (en) Methods for inhibiting bone loss
AU1969997A (en) Methods and apparatus for dispensing compositions
AU6099596A (en) Methods and compositions for effecting homologous recombination
AU6485996A (en) Methods and compositions for modulation and inhibition of teomerase
AU7200096A (en) Methods and compositions for controlling biofouling using amides
AU695703B2 (en) Improved photopolymerizable compositions
AU4928896A (en) Methods and compositions for altering sexual behavior
EP0831920A4 (en) Novel cathepsin and methods and compositions for inhibition thereof
AU5207696A (en) Highly fluidized concrete composition
AU7749394A (en) Methods for inhibiting uterine fibrosis
AU5301296A (en) Methods and compositions for regulating fadd
AU7685798A (en) Compositions and methods for preventing adhesion
AU4425696A (en) Polymerizable compounds and compositions
AU4928596A (en) Coolant compositions
AU5743396A (en) Methods for inhibiting bone loss
AU7717894A (en) Method and composition for weight reduction